Treatment of Chronic Bacterial Prostatitis in Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) with Pelvic Pain
This protocol addresses chronic bacterial prostatitis in men presenting with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) — defined by pain or discomfort in the pelvic region persisting for at least three months within the past six months, with no identifiable cause identified.
Clinical Scenario
CP/CPPS is a diagnosis of exclusion. Men with this condition experience pelvic pain or discomfort for at least three months within the past six months in the absence of identifiable causes of pain. The clinical picture is defined by the persistence and location of pain rather than by a specific structural or infectious finding.
Treatment Approach
Management is built around a multimodal non-surgical strategy that addresses pelvic pain, voiding symptoms, and quality of life through a coordinated combination of lifestyle-based, pharmacological, and procedural interventions — individually tailored to the patient's dominant symptom cluster. The complete structured regimen, including specific intervention types and sequencing, is available via the link below.
Treatment Goals
- Improvement in NIH-CPSI total score by 6 or more points
- Reduction in pelvic pain and discomfort
- Improvement in quality of life and daily functioning
References
- Men with CP/CPPS have pain or discomfort in the pelvic region for at least three months within the past six months in the absence of identifiable causes of pain.
- CP/CPPS is a diagnosis of exclusion.
- In patients with CP/CPPS, clinicians may discuss lifestyle modification, including dietary changes and aerobic exercise.
- In patients with CP/CPPS and voiding symptoms, clinicians should offer treatment with an alpha-blocker.
- Clinicians may prescribe anti-inflammatory agents as part of a multi-modal pain management strategy for treatment of pain in patients with CP/CPPS.
- In patients with CP/CPPS, clinicians may offer cognitive behavioral therapy as an adjunct to other therapeutic interventions.
- In patients with CP/CPPS, clinicians should discuss low-intensity extracorporeal shockwave therapy.
- Treatment response was defined as a reduction of ≥6 in total NIH-CPSI score.
- However, most patients are able to achieve an acceptable QOL and good daily functioning.
DOI: 10.1097/JU.0000000000004564
View source ↗